About Daniel Raynor
Daniel Raynor is a Managing Partner and co-founder of Argentum. In addition to leading new investments and co-managing the firm, Dan is an active board member of Argentum’s portfolio companies and an advisor to Argentum’s CEOs.
Dan has more than 25 years of private equity experience and has led nearly 40 investments for Argentum and served on a similar number of boards of directors. Dan’s areas of expertise include technology-enabled services, business services, healthcare & pharmaceutical services and logistics.
Prior to co-founding Argentum in 1988, Dan was Senior Vice President, Corporate Finance at Steinberg & Lyman (now Healthcare Ventures, LLC), a leading venture capital firm focused on the healthcare industry, and Assistant to the CEO & Chairman of ICN Pharmaceuticals, Inc. (now Valeant Pharmaceuticals).
Dan received a B.S. in economics from The Wharton School, University of Pennsylvania. Dan is an avid runner, cyclist and skier.